Galván CasasC.CatalàA.Carretero HernándezGet al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77.doi:10.1111/bjd.1916332348545
2.
ColmeneroI.SantojaC.Alonso RiañoMet al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020.doi:10.1111/bjd.19327
3.
Gómez-FernándezC.López-SundhAE.González-VelaMC. High prevalence of cryofibrinogenaemia in patients with chilblains during the COVID-19 ourbreak. Int J Dermatol. 2020.doi:10.1111/ijd.15234
4.
LadhaMA.LucaN.ConstantinescuC.NaertK.RamienM. Approach to chilblains during the COVID-19 pandemic. J Cutan Med Surg. 2020.doi:10.1177/1203475420937978
5.
BlainH.CacoubP.MussetLet al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120(2):253-260.doi:10.1046/j.1365-2249.2000.01210.x10792373